These results indicated that (RGD)3-tTF fusion protein could specifically gather in colorectal tumor blood vessels through the specific binding of RGD peptides and αvβ3 receptors of tumor vessels, while the free TF without RGD peptides guiding delivery could not assemble at the tumor sites. The gene discussed is RHOH; the disease is neoplasm.